Innate Pharma (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Innate Pharma - ADR: Is Infosys Ltd. worth buying?
Item: Innate Pharma - ADR
Rating: 0.69375
Author: Trendlyne DVM scores

about

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through ...

1.37 -0.14 (-9.27%)

47.91% Fall from 52W High

29,097

XNAS Volume

XNAS 07 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Innate Pharma (ADR) is on 13 May 2026 for the purpose of Innate Pharma SA First Quarter Earnings Result for 2026 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

27.8 / 100

1Yr Price target upside is 338%

4 analysts

Innate Pharma (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..